Results 81 to 90 of about 1,945 (206)

Dysfibrinogenemia and hypofibrinogenemia - Spectrum of pathogenic variants in Slovak patients

open access: yesBiomedical Papers
Introduction. Congenital hypofibrinogenemia (CH) and congenital dysfibrinogenemia (CD) are rare coagulation disorders caused by quantitative or qualitative defects in the fibrinogen gene.
Dominika Jaraskova   +11 more
doaj   +1 more source

Washington University Record, November 14, 1991 [PDF]

open access: yes, 1991
https://digitalcommons.wustl.edu/record/1566/thumbnail ...

core   +1 more source

Comparison of Hemostatic Activity in Canine Leukoreduced Cryoprecipitate, Cryopoor Plasma, and Fresh Plasma

open access: yesVeterinary Clinical Pathology, Volume 54, Issue 2, Page 120-131, June 2025.
ABSTRACT Background To date, no studies have reported the evaluation of hemostatic activity in canine leukoreduced cryoprecipitate (LR‐CRYO) and leukoreduced cryopoor plasma (LR‐CPP). Objectives We aimed to compare the hemostatic activity of LR‐CRYO and LR‐CPP to leukoreduced fresh plasma (LR‐FP) and to evaluate the preservation of LR‐CRYO by ...
Roberta Perego   +7 more
wiley   +1 more source

Phenotype, genotype, and laboratory assessment of congenital fibrinogen disorders:Data from the Rare Bleeding disorders in the Netherlands study [PDF]

open access: yes
Introduction: Congenital fibrinogen disorders (CFDs), encompassing quantitative (hypo−/afibrinogenemia) and qualitative (dysfibrinogenemia) defects, can result in bleeding or thrombotic events.
Blijlevens, Nicole M.A.   +11 more
core   +3 more sources

Fibrin monomers derived from thrombogenic dysfibrinogenemia, Naples-type variant (BβAla68Thr), showed almost entirely normal polymerization [PDF]

open access: yes, 2018
ArticleTHROMBOSIS RESEARCH.172:1-3(2018)journal ...
Arai, Shinpei   +5 more
core   +1 more source

Identification of Risk Factors and Predictive Indicators for Tigecycline‐Associated Hypofibrinogenemia

open access: yesClinical and Translational Science, Volume 18, Issue 4, April 2025.
ABSTRACT To investigate the prevalence, clinical manifestations, and risk factors of hypofibrinogenemia after tigecycline use, which can disrupt coagulation and potentially hinder antimicrobial therapy. This observational study was conducted from January to December 2021 at a tertiary general hospital in China.
Xiaohui Liu   +5 more
wiley   +1 more source

Novel heterozygous dysfibrinogenemia, Sumida (A alpha C472S), showed markedly impaired lateral aggregation of protofibrils and mildly lower functional fibrinogen levels [PDF]

open access: yes, 2015
Introduction: We encountered a 6-year-old girl with systemic lupus erythematosus. Although no bleeding or thrombotic tendency was detected, routine coagulation screening tests revealed slightly lower plasma fibrinogen levels, as determined by functional ...
Arai, Shinpei   +5 more
core   +1 more source

Acquired hypofibrinogenemia: current perspectives

open access: yesJournal of Blood Medicine, 2016
Martin W Besser,1 Stephen G MacDonald2 1Department of Haematology, 2Department of Specialist Haemostasis, The Pathology Partnership, Addenbrooke’s Hospital, Cambridge, UK Abstract: Acquired hypofibrinogenemia is most frequently caused by ...
Besser MW, MacDonald SG
doaj  

Hemostatic Balance in Pediatric Acute Liver Failure: Epidemiology of Bleeding and Thrombosis, Physiology, and Current Strategies

open access: yesFrontiers in Pediatrics, 2020
Pediatric Acute Liver Failure (PALF) is a rapidly progressive clinical syndrome encountered in the pediatric ICU which may rapidly progress to multi-organ dysfunction, and on occasion to life threatening cerebral edema and hemorrhage.
Yonca Bulut, Anil Sapru, Gavin D. Roach
doaj   +1 more source

c.259A>C in the fibrinogen gene of alpha chain (FGA) is a fibrinogen with thrombotic phenotype

open access: yesThe Application of Clinical Genetics, 2019
Ophira Salomon,1 Ortal Barel,2 Eran Eyal,2 Reut Shnerb Ganor,3 Yeroham Kleinbaum,4 Mordechai Shohat2 1Institute of Thrombosis and Hemostasis, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; 2Cancer Research ...
Salomon O   +5 more
doaj  

Home - About - Disclaimer - Privacy